Validity of the Montreal Cognitive Assessment (MoCA) as a screening test for Mild Cognitive Impairment (MCI) in a cardiovascular population. McLennan SN, Mathias JL, Brennan LC, Stewart S. Analysis of cognitive dysfunction with Silent Cerebral Infarction: A prospective study in Chinese patients. Zhao J, Tang H, Sun J, Wang B, Chen S, Fu Y. Mild cognitive impairment in symptomatic and asymptomatic cerebrovascular disease. Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults. Trzepacz PT, Hochstetler H, Wang S, Walker B, Saykin AJ. Brief cognitive screening instruments: An update. The Montreal cognitive assessment is superior to the minimental state examination in detecting patients at higher risk of dementia. 2005 53:695–9.ĭong YH, Lee WY, Basri NA, Collinson SL, Merchant RA, Venketasubramanian N, et al. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment. Nasreddine ZS, Phillips NA, BÃ©dirian V, Charbonneau S, Whitehead V, Collin I, et al. Mini-Mental State Examination: a 30-year story. The association between SBP and mortality risk differs with level of cognitive function in very old individuals. Weidung B, Littbrand H, Nordström P, Carlberg B, Gustafson Y. Effects of biological age on the associations of blood pressure with cardiovascular and non-cardiovascular mortality in old age: A population-based study. Liang Y, Fratiglioni L, Wang R, Santoni G, Welmer AK, Qiu C. Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs. Mossello E, Pieraccioli M, Nesti N, Bulgaresi M, Lorenzi C, Caleri V, et al. 2018 practice guidelines for the management of arterial hypertension of the European society of cardiology and the European society of hypertension ESC/ESH task force for the management of arterial hypertension. Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task F. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. Hypertension and dementia: Epidemiological and experimental evidence revealing a detrimental relationship. The Prevention of Dementia With Antihypertensive TreatmentNew Evidence From the Systolic Hypertension in Europe (Syst-Eur) Study. Antihypertensive treatment can prevent stroke and cognitive decline. Sörös P, Whitehead S, Spence JD, Hachinski V. MoCA, MMSE and MiniCog showed similar discriminative ability for cognitive impairment, with MoCa and MMSE showing greater sensitivity and MiniCog the highest specificity. Cognitive impairment was detected in more than one-third of hypertensive older adults without prior diagnosis of dementia. The sensitivity of MoCA (80%) and of MMSE/MiniCog combination (74%) was higher in comparison with MiniCog alone (49%, p = 0.007 and 0.004, respectively), while MiniCog achieved the highest specificity (88%, p < 0.001 vs all). The MoCA (AUC = 0.746), the MMSE (AUC = 0.689) and the MiniCog (AUC = 0.684) showed similar ability in detecting cognitive impairment, while the CDT had a poorer discriminative capacity (AUC = 0.535). Cognitive impairment was diagnosed in 37% of 94 participants (mean age 76, 55% female), mainly involving attention and executive functions. The ROC curve analysis and the paired chi-square test were used to compare the discriminative ability, sensitivity and specificity for cognitive impairment of the different screening instruments. Mini Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), MiniCog and Clock Drawing Test (CDT) were administered, using a comprehensive neuropsychological assessment as gold standard. The study involved hypertensive patients aged 65+ without prior diagnosis of cognitive impairment, from the Hypertension Clinic of Careggi Hospital, Florence, Italy. This study investigated cognitive impairment in hypertensive older adults and compared the discriminative ability of the most widely used cognitive screening tests. Yet, the most suitable cognitive screening test for hypertensive patients has yet to be identified. Hypertension is a major risk factor for dementia.

Moca test cutoff scores